Transforming metabolic data into personalized medicine

AI-driven metabolomic platform empowering fertility providers with actionable insights for personalized treatments and enhanced noninvasive embryo selection.
About us
Noninvasive

Embryo analysis without harm, ensuring safety throughout the process.

Affordable

Cost-effective solution, making advanced technologies accessible to a broader range of users.

Rapid

Reduced turnaround time compared to traditional embryo screening methods, delivering faster results.

For Fertility Clinics

Discover more

For Researchers

Discover more

Leading the Innovation in
Microscale Magnetic
Resonance Spectroscopy (MRS)

About us

Latest press release

September 2, 2025 in news

Core Patent Granted in Israel

Our patent 281764 for a ‘Miniaturized Magnetic Resonance Device’ has been granted in Israel, following granting in the USA, EU, China and Japan. Patent details
Read More

Upcoming event

9th SIRU National Congress

Date iconApril 16, 2026
Date icon Siena, Italy
View the event

New publication

Publication icon

Micro magnetic resonance spectroscopy for noninvasive metabolic screening of mammalian embryos and oocytes

2025
View the publication
View all
Press releasesEventsPublications
Our partners